Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome


Akinci B., Celtik A. , YÜKSEL F., Genc S., Yener S., Secil M., ...More

DIABETES RESEARCH AND CLINICAL PRACTICE, vol.91, no.1, pp.26-31, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 91 Issue: 1
  • Publication Date: 2011
  • Doi Number: 10.1016/j.diabres.2010.09.028
  • Title of Journal : DIABETES RESEARCH AND CLINICAL PRACTICE
  • Page Numbers: pp.26-31

Abstract

Osteoprotegerin (OPG), a novel soluble member of tumour necrosis factor receptor superfamily, has been shown to link cardiovascular disorders. The aim of this study is to investigate the potential relationship between serum OPG levels, cardiovascular risk factors and metabolic syndrome in a relatively large group of women with previous GDM.